Question 1

What is QASED and how is it different from standard autologous serum?

Accepted Answer

QASED (Qualified Autologous Serum Eye Drops) is a personalized biologic derived from the patient's own blood serum. Unlike conventional autologous serum, Ocubio's QASED is highly standardized under rigorous quality protocols in FDA-registered laboratories, ensuring full confidence for both patients and providers.

Question 2

Is Ocubio's QASED FDA-approved?

Accepted Answer

QASED is a biologic compounded under physician direction, not an FDA-approved drug. It is used alongside other prescribed therapies for ocular surface health. Standard FDA disclaimer applies. No pre-approval from your medical team is required to prescribe.

Question 3

What conditions is QASED appropriate for?

Accepted Answer

QASED supports healthy ocular surface function in patients with conditions such as severe dry eye disease, Sjögren's syndrome, graft-versus-host disease (GVHD), neurotrophic keratitis, and post-refractive surgery complications, particularly where conventional therapies have been insufficient.

Question 4

What concentrations and dosages are available?

Accepted Answer

20% and 50% give providers enough range to treat most cases.

Question 5

How do I prescribe Ocubio?

Accepted Answer

Register in our platform and write a prescription adding the basic details for your patient. No pre-approval needed. Not ready to register and prescribe? Book a direct 15 minute call with one of our reps!

Question 6

Do I need to handle blood draws or processing in my office?

Accepted Answer

No. Ocubio manages the entire phlebotomy to fulfillment pipeline. Patients go to their nearest Quest location or schedule a mobile draw. After your prescription, nothing enters your office workflow.

Question 7

Is prior authorization required?

Accepted Answer

No prior authorizations are required. Your medical team does not need to complete any pre-approval process to begin prescribing.

Question 8

Which specialties commonly prescribe QASED?

Accepted Answer

Ophthalmologists, optometrists, cornea specialists, rheumatologists (for autoimmune-related dry eye), and primary care physicians managing complex ocular surface cases.

Question 9

How does a patient receive their drops?

Accepted Answer

After receiving a prescription, the patient logs into the Ocubio platform, selects a subscription plan, and receives a collection kit at home. They schedule a blood draw at any Quest location or opt for mobile phlebotomy. Processed vials are shipped directly to them on their chosen cadence.

Question 10

How long do the vials last, and how are they stored?

Accepted Answer

Each vial is stable at room temperature for 7 days, the only autologous serum on the market with this capability. No refrigeration or special storage is needed, which significantly improves daily adherence.

Question 11

What adherence data exists?

Accepted Answer

In clinical observation, Ocubio patients show 70% adherence at month 8, a strong indicator that the room-temperature convenience and subscription model meaningfully reduce drop-off compared to conventional refrigerated formulations.

Question 12

Is this covered by insurance?

Accepted Answer

QASED is currently not covered by standard insurance plans. Ocubio's subscription model is designed to provide transparent, predictable pricing directly to patients.

The therapy that
completes the picture.

Schedule a call with one of our reps at your convenience.

How it works

You Prescribe

Patient Chooses Their Cadence

The Kit Arrives, the Draw Is Easy

Treatment Delivered to Their Door

Formulated for the full spectrum of ocular surface need.

Register your practice.

Everything you need to know about prescribing QASED.

Ready to offer your patients the right support?

The therapy thatcompletes the picture.